0

    531541

    KOBO

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    KOBO BIOTECH LIMITED Share Price Today

    Investment Returns

    Over 1 Month 25.41% Over 3 Months 218.59% Over 6 Months 300.00% Over 1 Year 288.03%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    KOBO BIOTECH LIMITED fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 21.20
    • P/E Ratio (TTM) -4.13
    • Beta 0.54
    • Book Value / share -57.98
    • Return on equity 0.00%
    • EPS (TTM) 0.00
    • Dividend yield [-]%
    • Net profit/quarter (Cr) -1.33
    info icon alternate text

    KOBO BIOTECH LIMITED Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars JUN 2024 (Values in Cr)
    Revenue 0.00
    Operating Expense 1.35
    Net Profit -1.33
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) -0.56
    EBITDA -0.32
    Effective Tax Rate (%) 0.00
    Particulars MAR 2024 (Values in Cr)
    Revenue 0.00
    Operating Expense 1.26
    Net Profit -1.26
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) -0.53
    EBITDA -0.25
    Effective Tax Rate (%) 0.00
    Particulars DEC 2023 (Values in Cr)
    Revenue 0.00
    Operating Expense 1.23
    Net Profit -1.23
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) -0.52
    EBITDA -0.19
    Effective Tax Rate (%) 0.00
    Particulars SEP 2023 (Values in Cr)
    Revenue 0.00
    Operating Expense 1.22
    Net Profit -1.22
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) -0.51
    EBITDA -0.19
    Effective Tax Rate (%) 0.00
    Particulars JUN 2023 (Values in Cr)
    Revenue 0.00
    Operating Expense 1.24
    Net Profit -1.23
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) -0.51
    EBITDA -0.21
    Effective Tax Rate (%) 0.00
    Particulars MAR 2024 (Values in Cr)
    Revenue 0.00
    Operating Expense 4.94
    Net Profit -4.93
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) -2.07
    EBITDA -0.85
    Effective Tax Rate (%) 0.00
    Particulars MAR 2023 (Values in Cr)
    Revenue 0.00
    Operating Expense 5.57
    Net Profit -5.55
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) -2.33
    EBITDA -1.47
    Effective Tax Rate (%) 0.00
    Particulars MAR 2022 (Values in Cr)
    Revenue 0.00
    Operating Expense 15.24
    Net Profit -15.23
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) -6.39
    EBITDA -10.48
    Effective Tax Rate (%) 0.00
    Particulars MAR 2021 (Values in Cr)
    Revenue 0.00
    Operating Expense 19.27
    Net Profit -19.23
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) -8.07
    EBITDA -2.75
    Effective Tax Rate (%) 0.00
    Particulars MAR 2020 (Values in Cr)
    Revenue 0.00
    Operating Expense 21.04
    Net Profit -21.01
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) -8.82
    EBITDA -0.66
    Effective Tax Rate (%) 0.00
    Particulars MAR 2015 (Values in Cr)
    Book Value / Share 23.59
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 3.38
    EBITDA Margin -0.64
    Particulars MAR 2014 (Values in Cr)
    Book Value / Share 23.59
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 2.56
    EBITDA Margin -0.64
    Particulars MAR 2013 (Values in Cr)
    Book Value / Share 39.06
    ROE % 16.72
    ROCE % 12.63
    Total Debt to Total Equity 1.83
    EBITDA Margin 10.45
    Particulars MAR 2012 (Values in Cr)
    Book Value / Share 32.84
    ROE % 22.13
    ROCE % 17.30
    Total Debt to Total Equity 1.82
    EBITDA Margin 16.66
    Particulars MAR 2011 (Values in Cr)
    Book Value / Share 27.29
    ROE % 14.91
    ROCE % 10.76
    Total Debt to Total Equity 2.14
    EBITDA Margin 17.19
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share -57.98
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.00
    EBITDA Margin 0.00
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share -55.79
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.00
    EBITDA Margin 0.00
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share -53.72
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.00
    EBITDA Margin 0.00
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share -51.39
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.00
    EBITDA Margin 0.00
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share -45.00
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.00
    EBITDA Margin 0.00
    Particulars MAR 2015 (Values in Cr)
    Cash & Short Term Investments 5.64
    Total Assets 395.57
    Total Liabilities 395.57
    Total Equity 53.07
    Share Outstanding 2
    Price to Book Ratio 4.42
    Return on Assets (%) -8.80
    Return on Capital (%) -15.51
    Particulars MAR 2014 (Values in Cr)
    Cash & Short Term Investments 16.47
    Total Assets 411.67
    Total Liabilities 411.67
    Total Equity 87.89
    Share Outstanding 2
    Price to Book Ratio 0.44
    Return on Assets (%) 3.39
    Return on Capital (%) 5.73
    Particulars MAR 2013 (Values in Cr)
    Cash & Short Term Investments 16.47
    Total Assets 411.67
    Total Liabilities 411.67
    Total Equity 87.89
    Share Outstanding 2
    Price to Book Ratio 0.41
    Return on Assets (%) 3.39
    Return on Capital (%) 5.73
    Particulars MAR 2012 (Values in Cr)
    Cash & Short Term Investments 25.13
    Total Assets 345.60
    Total Liabilities 345.60
    Total Equity 75.65
    Share Outstanding 2
    Price to Book Ratio 1.00
    Return on Assets (%) 4.37
    Return on Capital (%) 8.65
    Particulars MAR 2011 (Values in Cr)
    Cash & Short Term Investments 2.49
    Total Assets 249.98
    Total Liabilities 249.98
    Total Equity 61.40
    Share Outstanding 2
    Price to Book Ratio 1.26
    Return on Assets (%) 3.93
    Return on Capital (%) 5.51
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 4.35
    Total Assets 71.59
    Total Liabilities 71.59
    Total Equity -138.14
    Share Outstanding 2
    Price to Book Ratio -0.05
    Return on Assets (%) -7.30
    Return on Capital (%) -337.19
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.18
    Total Assets 71.39
    Total Liabilities 71.39
    Total Equity -132.91
    Share Outstanding 2
    Price to Book Ratio -0.07
    Return on Assets (%) -6.90
    Return on Capital (%) -72.69
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.12
    Total Assets 75.33
    Total Liabilities 75.33
    Total Equity -127.98
    Share Outstanding 2
    Price to Book Ratio -0.04
    Return on Assets (%) -7.37
    Return on Capital (%) -46.83
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 0.12
    Total Assets 79.18
    Total Liabilities 79.18
    Total Equity -122.42
    Share Outstanding 2
    Price to Book Ratio -0.11
    Return on Assets (%) -19.22
    Return on Capital (%) -83.26
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 1.55
    Total Assets 230.58
    Total Liabilities 230.58
    Total Equity -107.20
    Share Outstanding 2
    Price to Book Ratio -0.16
    Return on Assets (%) -8.34
    Return on Capital (%) -12.54
    Particulars MAR 2015 (Values in Cr)
    Net Income -34.27
    Cash from Operations 7.26
    Cash from Investing -4.70
    Cash from Financing -12.84
    Net change in Cash -10.83
    Free Cash Flow 11.96
    Particulars MAR 2014 (Values in Cr)
    Net Income 14.87
    Cash from Operations 38.50
    Cash from Investing -6.99
    Cash from Financing -38.38
    Net change in Cash -8.65
    Free Cash Flow 46.35
    Particulars MAR 2013 (Values in Cr)
    Net Income 14.87
    Cash from Operations 38.50
    Cash from Investing -6.99
    Cash from Financing -38.38
    Net change in Cash -8.65
    Free Cash Flow 46.35
    Particulars MAR 2012 (Values in Cr)
    Net Income 17.67
    Cash from Operations 65.88
    Cash from Investing -14.43
    Cash from Financing -26.81
    Net change in Cash 22.63
    Free Cash Flow 80.34
    Particulars MAR 2025 (Values in Cr)
    Net Income -5.22
    Cash from Operations 4.17
    Cash from Investing 0.00
    Cash from Financing 0.00
    Net change in Cash 4.17
    Free Cash Flow 4.17
    Particulars MAR 2024 (Values in Cr)
    Net Income -4.92
    Cash from Operations 0.20
    Cash from Investing 0.00
    Cash from Financing -0.15
    Net change in Cash 0.05
    Free Cash Flow 0.20
    Particulars MAR 2023 (Values in Cr)
    Net Income -5.55
    Cash from Operations 0.87
    Cash from Investing 0.00
    Cash from Financing -0.87
    Net change in Cash 0.00
    Free Cash Flow 0.87
    Particulars MAR 2022 (Values in Cr)
    Net Income -15.22
    Cash from Operations 93.75
    Cash from Investing 25.09
    Cash from Financing -120.28
    Net change in Cash -1.43
    Free Cash Flow 93.75
    Particulars MAR 2021 (Values in Cr)
    Net Income -19.23
    Cash from Operations 2.50
    Cash from Investing 0.00
    Cash from Financing -1.07
    Net change in Cash 1.43
    Free Cash Flow 2.50
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 32.67 13.56 1.58 250.36 23.12 38.85
    BLISS GVS PHARMA LTD 462.85 37.21 4.11 4908.81 118.35 552.90
    CIPLA LTD. 1393.75 31.46 3.27 112593.44 1165.55 1672.20
    FERMENTA BIOTECH LTD. 401.95 18.80 2.90 1182.98 256.40 480.00
    GLAXOSMITHKLINE PHARMA LT 2494.20 43.91 18.63 42253.25 2088.00 3217.10
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 32.67 22.85 4.20 250.36 23.12 38.85
    AMRUTAJAN HEALTH LTD 518.15 23.23 4.04 1498.00 490.00 789.95
    ASTRAZENECA PHARMA INDIA LTD. 7873.60 102.90 22.55 19684.00 7630.00 9850.00
    BLISS GVS PHARMA LTD 462.85 50.04 4.24 4908.81 118.35 552.90

    KOBO BIOTECH LIMITED shareholding pattern

    Holding
    55.05%
    44.94%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    KOBO BIOTECH LIMITED Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    8.90 -1.98 redarrow
    red-green-graph indicator
    8 Bearish
    8 Bullish
    • 5 Days 9.30
    • 26 Days 8.30
    • 10 Days 9.20
    • 50 Days 7.00
    • 12 Days 9.20
    • 100 Days 5.40
    • 20 Days 8.70
    • 200 Days 4.20
    9.08 PIVOT
    First Support 9.08 First Resistance 9.08 Second Support 9.08 Second Resistance 9.08 Third Support 9.08 Third Resistance 9.08
    RSI 69.97 ADX 88.17 MACD 0.85 Williams % R -58.71 Commodity Channel Index (CCI) 28.05
    Date 2026-07-23 Week 174100.00 Same Day 246.00 Month 97163.00
    1 Year 0.54 3 Year 0.41
    Over 1 Month
    25.41% down
    Over 1 Year
    288.03% down
    Over 3 Months
    218.59% down
    Over 3 Years
    62.14% down
    Over 6 Months
    300.00% down
    Over 5 Years
    4.95% down

    KOBO BIOTECH LIMITED Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    21 Sep 2012 1.0 Final 25 Sep 2012 Equity shares
    22 Jul 2011 1.0 Final 26 Jul 2011 Equity shares
    23 Sep 2010 1.0 Final 25 Sep 2010 Equity shares

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Kobo Biotech Ltd?

    Answer Field

    Kobo Biotech Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 8.90 as on Jul 24 2026 12:15 PM.

    What is the Market Cap of Kobo Biotech Ltd Share?

    Answer Field

    The market cap of Kobo Biotech Ltd for NSE ₹ 0.00 & for BSE ₹ 21.20 as on Jul 24 2026 12:15 PM.

    What is the 52 Week High and Low of Kobo Biotech Ltd?

    Answer Field

    The 52 Week High and Low of Kobo Biotech Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 9.99 and ₹ 1.99.

    What is 1 year return for Kobo Biotech Ltd?

    Answer Field

    The 1 year returns on the stock has been 288.03%.

    What is the P/E Ratio of Kobo Biotech Ltd Share?

    Answer Field

    As on Jul 24 2026 12:15 PM the price-to-earnings (PE) ratio for Kobo Biotech Ltd share is -4.13.

    What is the PB ratio of Kobo Biotech Ltd Share?

    Answer Field

    As on Jul 24 2026 12:15 PM, the price-to-book (PB) ratio for Kobo Biotech Ltd share is -57.98.

    How to Buy Kobo Biotech Ltd Share?

    Answer Field

    You can trade in Kobo Biotech Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Kobo Biotech Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Kobo Biotech Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Kobo Biotech Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |